July 8, 2015—Pharmaceutical manufacturers AstraZeneca, Biogen Idec, and Cephalon have agreed to pay a combined $55.5 million to settle a whistleblower’s claims they defrauded the federal government and 24 states by underpaying Medicaid drug rebates.
You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register. Already registered? Click here to login. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)